Lyra Therapeutics所有資訊

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Point72 Asset Management, L.P.(0%),Point72 Capital Advisors, Inc.(0%)等

11/14 19:52 (美東)

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Samsara BioCapital, L.P.(4.98%),Samsara BioCapital GP, LLC(4.98%)等

11/14 17:51 (美東)

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(1.8%),VHCP Co-Investment Holdings II, LLC(1.8%)等

11/14 17:51 (美東)

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Vestal Point Capital, LP(0%),Ryan Wilder(0%)

11/14 12:08 (美東)

Lyra Therapeutics | 4：持股變動聲明-高管 Palasis Maria

10/18 16:09 (美東)

Lyra Therapeutics | 4：持股變動聲明-高管 Cavalier Jason

10/18 16:09 (美東)

Lyra Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(19.5%),Joseph Edelman(19.5%)等

08/15 18:32 (美東)

Lyra Therapeutics | 4：持股變動聲明-董事 ALTMAN MICHAEL SETH

06/14 16:16 (美東)

Lyra Therapeutics | 4：持股變動聲明-董事 Poukalov Konstantin

06/14 16:15 (美東)

Lyra Therapeutics | 4：持股變動聲明-董事 TOBIN JAMES R

06/14 16:15 (美東)

Lyra Therapeutics | 4：持股變動聲明-董事 snyderman nancy lynn MD

06/14 16:15 (美東)

Lyra Therapeutics | 4：持股變動聲明-董事 Smith W Bradford

06/14 16:15 (美東)

Lyra Therapeutics | 4：持股變動聲明-董事 MERRIFIELD C ANN

06/14 16:15 (美東)

Lyra Therapeutics | 4：持股變動聲明-高管 Waksal Harlan

03/20 19:23 (美東)

Lyra Therapeutics | 4：持股變動聲明-高管 Palasis Maria

03/20 19:23 (美東)

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.999%),VHCP Co-Investment Holdings II, LLC(9.999%)等

02/14 20:38 (美東)

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Citadel Advisors LLC(7.9%),Citadel Advisors Holdings LP(7.9%)等

02/14 18:23 (美東)

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Steven A. Cohen(5.8%),Point72 Asset Management, L.P.(5.7%)等

02/14 17:41 (美東)

Lyra Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Nantahala Capital Management, LLC(8.9%),Wilmot B. Harkey(8.9%)等

02/14 16:58 (美東)

Lyra Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(24.3%),Joseph Edelman(24.3%)等

02/14 16:37 (美東)